Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound MEDLINE
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(fetotoxic)
316 results
  • Update on pregnancy complications in systemic lupus erythematosus. [Journal Article]
    Curr Opin Rheumatol 2019; 31(6):650-658Marder W
  • CONCLUSIONS: Outcomes of lupus pregnancies continue to improve with understanding of risk factors that predict APOs as well as improvements in disease management. Rheumatologists caring for women with SLE should be familiar with the most up-to-date research in order to optimize pregnancy outcomes in this population.
  • Treatment and Prevention of Hypertensive Disorders During Pregnancy. [Review]
    Clin Perinatol 2019; 46(2):173-185Leavitt K, Običan S, Yankowitz J
  • This article reviews the pharmacology of the most commonly used antihypertensive medications during pregnancy; their mechanism of action; and the effects on the mother, the fetus, and lactation. Each class of antihypertensive pharmacologic agents have specific mechanisms of action by which they exert their antihypertensive effect. β-Adrenoreceptor antagonists block these receptors in the peripher…
  • Antiparasitic treatments in pregnant women: Update and recommendations. [Review]
    Med Mal Infect 2018Boitel E, Desoubeaux G
  • Parasitoses are a major cause of morbidity and mortality worldwide, especially in resource-poor countries where the prevalence of such infections is very high. Their consequences for pregnant women are a public health issue. It is very challenging to successfully control parasitic infections with the dedicated drugs, while protecting the fetus from the harmful effects of these medications. Howeve…
  • Contraception Use Among Reproductive-Age Women With Rheumatic Diseases. [Journal Article]
    Arthritis Care Res (Hoboken) 2019; 71(8):1132-1140Birru Talabi M, Clowse MEB, … Borrero S
  • CONCLUSIONS: This is the largest study to date to describe contraceptive use among reproductive-age women with rheumatic diseases, and the findings reveal low use of prescription contraception. Urgent efforts are needed to improve contraceptive care and access for some women with rheumatic diseases.
New Search Next